Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Solasta Ventures, Inc. is a wholly-owned subsidiary of Aju IB Investment, a prominent South Korean venture capital firm. Established in 2019, Solasta Ventures operates from its office located at Prudential Tower, 800 Boylston Street, Suite 2510, Boston, MA 02199. The firm focuses on investing in innovative companies that aim to improve care for diseases with unmet medical needs. Solasta Ventures leverages scientific expertise and a broad network to identify promising therapeutics and discovery platforms, primarily in the life sciences sector.
As of now, Solasta Ventures has made 29 total investments, with a portfolio comprising 26 companies and 6 notable exits. The firm emphasizes partnerships with strong management teams capable of effectively utilizing capital for long-term value creation. Their strategic approach includes collaborations with global pharmaceutical companies, particularly leveraging their connections within the South Korean pharmaceutical ecosystem.
Solasta Ventures invests primarily in the life sciences sector, specifically targeting therapeutics and technologies that can transform patient care in both U.S. and global markets. The firm seeks to partner with strong management teams that can effectively utilize capital and prioritize assets for long-term value creation. Their investment strategy includes a focus on early-stage startups, particularly those with novel science that advances the standard of care for diseases with unmet medical needs.
The firm typically invests in Seed, Series A, and Series B stages, with check sizes ranging from $1 million to $10 million. Solasta Ventures actively looks for opportunities for partnerships and collaborations with global pharmaceutical companies, particularly those within their South Korean network. This strategic focus allows them to enhance the potential for impactful innovations in healthcare.
Solasta Ventures has a diverse portfolio of 26 companies, with notable investments in the following:
These companies exemplify Solasta Ventures' commitment to investing in innovative solutions that address significant healthcare challenges.
Derek Yoon - President & CEO. Derek oversees all U.S.-based life science investments and serves on the board of several portfolio companies, including Arcellx, Carbon Biosciences, EvolveImmune Therapeutics, and Trefoil Therapeutics. He is connected to the Yale Ventures network and has a strong background in venture capital.
Katlyn Gabriel - Associate. Katlyn supports the investment team in sourcing and evaluating potential investments, contributing to the firm's strategic initiatives.
Nia Julian - Executive Assistant. Nia provides administrative support to the team, ensuring smooth operations within the firm.
Michael Jeon - Managing Partner. Michael plays a key role in guiding the firm's investment strategy and managing relationships with portfolio companies.
William C. Hahn, M.D., Ph.D. - Scientific Advisory Board. William brings extensive expertise in medical research and development, advising on scientific matters related to portfolio companies.
Byoung Chul Cho, M.D., Ph.D. - Scientific Advisory Board. Byoung contributes his knowledge in the life sciences, providing insights that enhance the firm's investment decisions.
Startups interested in pitching to Solasta Ventures should visit their website at solasta-ventures.com. It is recommended to include a comprehensive deck that outlines the business model, market opportunity, and team qualifications. The firm prefers to receive pitches through their website and values clear communication regarding the startup's vision and potential impact.
Response times may vary, but founders can expect to hear back within a few weeks. Warm introductions are beneficial but not strictly necessary for initial outreach.
As of April 2026, Solasta Ventures has made significant strides in the life sciences sector, with a total of 29 investments and 6 notable exits. The firm continues to focus on innovative therapeutics and technologies that address unmet medical needs.
Recent portfolio highlights include ongoing developments at companies like Arcellx and EvolveImmune Therapeutics, which are advancing their respective therapies in the biotech space. Solasta Ventures remains committed to fostering growth within its portfolio through strategic guidance and leveraging its extensive network.
What are Solasta Ventures' investment criteria?
Solasta Ventures focuses on innovative companies in the life sciences sector, particularly those with therapeutics and technologies that address unmet medical needs. They prefer to invest in early-stage startups, specifically in Seed, Series A, and Series B rounds.
How can startups apply or pitch to Solasta Ventures?
Startups can pitch to Solasta Ventures through their website at solasta-ventures.com. It is advisable to include a detailed deck that outlines the business model, market opportunity, and team qualifications.
What makes Solasta Ventures different from other VC firms?
Solasta Ventures leverages deep scientific expertise and a strong network within the South Korean pharmaceutical ecosystem, providing unique access to resources and potential partnerships that can enhance portfolio company growth.
What is the geographic scope of Solasta Ventures' investments?
The firm invests globally, with a particular focus on the U.S. market for life sciences companies. They actively seek opportunities that can benefit from their connections in South Korea.
What is the typical check size for investments?
Solasta Ventures typically invests between $1 million and $10 million in their portfolio companies, depending on the stage and potential of the business.
What kind of post-investment involvement does Solasta Ventures have?
Solasta Ventures actively engages with its portfolio companies, providing strategic guidance, operational support, and access to their extensive network to facilitate growth and development.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.